SMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SMS Pharmaceuticals Limited has submitted its financial results to the NSE for the period ended March 31, 2026. The filing is a standard quarterly/yearly results submission as required under listing regulations. The actual financial figures including revenue, profit after tax, EBITDA, and other key metrics are not available in this announcement summary. The complete financial statements would need to be reviewed for detailed performance analysis.
The submission fulfills the company's regulatory reporting obligation. The actual impact on the stock will depend on the detailed financial performance disclosed in the complete filing, which investors should review for informed decisions.